{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=midazolam+intravenous+infusion", "query": { "intervention": "midazolam intravenous infusion" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 50, "total_pages": 5, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=midazolam+intravenous+infusion&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-10-01T03:43:48.798Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01850017", "title": "Study of Dexmedetomidine in Spine Surgery", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Collapse of Thoracic Vertebra", "Collapse of Lumbar Vertebrae" ], "interventions": [ { "name": "Dexmedetomidine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Virginia", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 142, "start_date": "2012-08", "completion_date": "2015-05", "has_results": false, "last_update_posted_date": "2017-05-05", "last_synced_at": "2026-10-01T03:43:48.798Z", "location_count": 1, "location_summary": "Charlottesville, Virginia", "locations": [ { "city": "Charlottesville", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT01850017" }, { "nct_id": "NCT04912115", "title": "Randomized, Double-Blind, Active Placebo-Controlled Study of Ketamine to Treat Levodopa-Induced Dyskinesia", "overall_status": "SUSPENDED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Dyskinesias", "Movement Disorders", "Central Nervous System Diseases", "Nervous System Diseases", "Neurologic Manifestations" ], "interventions": [ { "name": "Ketamine", "type": "DRUG" }, { "name": "Midazolam", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "PharmaTher Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "30 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "30 Years to 85 Years" }, "enrollment_count": 30, "start_date": "2021-10-05", "completion_date": "2024-03-30", "has_results": false, "last_update_posted_date": "2023-11-18", "last_synced_at": "2026-10-01T03:43:48.798Z", "location_count": 7, "location_summary": "Tucson, Arizona • Chula Vista, California • Fountain Valley, California + 3 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Chula Vista", "state": "California" }, { "city": "Fountain Valley", "state": "California" }, { "city": "Miami", "state": "Florida" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04912115" }, { "nct_id": "NCT00947791", "title": "Treatment Study of Bipolar Depression", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Bipolar Disorder" ], "interventions": [ { "name": "ketamine", "type": "DRUG" }, { "name": "midazolam", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Icahn School of Medicine at Mount Sinai", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "21 Years to 70 Years" }, "enrollment_count": 1, "start_date": "2009-07", "completion_date": "2009-10", "has_results": true, "last_update_posted_date": "2017-05-17", "last_synced_at": "2026-10-01T03:43:48.798Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00947791" }, { "nct_id": "NCT02410460", "title": "Anesthetics in Rhytidoplasty - A Comparison Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Rhytidoplasty" ], "interventions": [ { "name": "clonidine", "type": "DRUG" }, { "name": "glycopyrrolate", "type": "DRUG" }, { "name": "propofol", "type": "DRUG" }, { "name": "ketamine", "type": "DRUG" }, { "name": "marcaine", "type": "DRUG" }, { "name": "scopolamine", "type": "DRUG" }, { "name": "midazolam", "type": "DRUG" }, { "name": "ondansetron", "type": "DEVICE" }, { "name": "metoclopramide", "type": "DRUG" }, { "name": "lidocaine", "type": "DRUG" }, { "name": "famotidine", "type": "DRUG" }, { "name": "desflurane", "type": "DRUG" }, { "name": "sevoflurane", "type": "DRUG" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "Mercy Facial Plastic Surgery Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 30, "start_date": "2013-09", "completion_date": "2014-06", "has_results": false, "last_update_posted_date": "2015-04-07", "last_synced_at": "2026-10-01T03:43:48.798Z", "location_count": 1, "location_summary": "Springfield, Missouri", "locations": [ { "city": "Springfield", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT02410460" }, { "nct_id": "NCT00579085", "title": "Double Blind Placebo Controlled Study of Outpatient Intravenous Ketamine for the Treatment of CRPS", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Complex Regional Pain Syndrome" ], "interventions": [ { "name": "Ketamine", "type": "DRUG" }, { "name": "IV NSS", "type": "OTHER" }, { "name": "Normal Saline", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Drexel University College of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 40, "start_date": "2006-09", "completion_date": "2009-11", "has_results": false, "last_update_posted_date": "2010-06-17", "last_synced_at": "2026-10-01T03:43:48.798Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT00579085" }, { "nct_id": "NCT00685230", "title": "Double-Blind, Alacramyn® vs. Placebo in Pediatric Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Scorpion Sting Envenomation" ], "interventions": [ { "name": "Antivenin Centruroides (scorpion) equine immune F(ab)2", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "Instituto Bioclon S.A. de C.V.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Months", "maximum_age": "18 Years", "sex": "ALL", "summary": "6 Months to 18 Years" }, "enrollment_count": 15, "start_date": "2004-05", "completion_date": "2005-10", "has_results": false, "last_update_posted_date": "2011-06-02", "last_synced_at": "2026-10-01T03:43:48.798Z", "location_count": 2, "location_summary": "Tucson, Arizona", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT00685230" }, { "nct_id": "NCT00768430", "title": "Optimization of IV Ketamine for Treatment Resistant Depression", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Major Depressive Disorder (MDD)", "Treatment Resistant Depression (TRD)" ], "interventions": [ { "name": "Ketamine", "type": "DRUG" }, { "name": "Midazolam", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Baylor College of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "21 Years to 80 Years" }, "enrollment_count": 73, "start_date": "2008-11", "completion_date": "2012-11", "has_results": true, "last_update_posted_date": "2014-01-31", "last_synced_at": "2026-10-01T03:43:48.798Z", "location_count": 2, "location_summary": "New York, New York • Houston, Texas", "locations": [ { "city": "New York", "state": "New York" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00768430" }, { "nct_id": "NCT03813121", "title": "The Effects of Sedatives on Tobacco Use Disorder", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Tobacco Use Disorder" ], "interventions": [ { "name": "midazolam intravenous infusion", "type": "DRUG" }, { "name": "placebo intravenous infusion", "type": "DRUG" }, { "name": "ketamine intravenous infusion", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Wake Forest University Health Sciences", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 10, "start_date": "2019-06-01", "completion_date": "2021-08-31", "has_results": true, "last_update_posted_date": "2022-10-06", "last_synced_at": "2026-10-01T03:43:48.798Z", "location_count": 1, "location_summary": "Little Rock, Arkansas", "locations": [ { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03813121" }, { "nct_id": "NCT05395104", "title": "A Study to Assess the Effect of Cefiderocol on the Pharmacokinetics (PK) of Midazolam in Healthy Participants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Volunteers" ], "interventions": [ { "name": "Midazolam", "type": "DRUG" }, { "name": "Cefiderocol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Shionogi", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 14, "start_date": "2022-05-24", "completion_date": "2022-07-13", "has_results": true, "last_update_posted_date": "2023-12-14", "last_synced_at": "2026-10-01T03:43:48.798Z", "location_count": 1, "location_summary": "San Antonio, Texas", "locations": [ { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT05395104" }, { "nct_id": "NCT04254783", "title": "A Study to Evaluate the Effect of Intravenous (IV) Infusions of Risankizumab on Pharmacokinetics of Cytochome P450 Substrates in Adult Participants With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Ulcerative Colitis (UC)", "Crohn's Disease" ], "interventions": [ { "name": "Risankizumab", "type": "DRUG" }, { "name": "Cytochrome P450 (CYP) Substrates", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AbbVie", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 20, "start_date": "2020-05-27", "completion_date": "2022-10-14", "has_results": false, "last_update_posted_date": "2024-07-01", "last_synced_at": "2026-10-01T03:43:48.798Z", "location_count": 4, "location_summary": "Coronado, California • DeLand, Florida • Margate, Florida + 1 more", "locations": [ { "city": "Coronado", "state": "California" }, { "city": "DeLand", "state": "Florida" }, { "city": "Margate", "state": "Florida" }, { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04254783" } ] }